Cargando…

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria

BACKGROUND: High epilepsy prevalence and incidence have been reported in areas with high onchocerciasis transmission. Recent findings suggest that proper community-directed treatment with ivermectin (CDTI) is potentially able to prevent onchocerciasis-associated epilepsy (OAE). We assessed the epile...

Descripción completa

Detalles Bibliográficos
Autores principales: Siewe, Joseph N. F., Ukaga, Chinyere N., Nwazor, Ernest O., Nwoke, Murphy O., Nwokeji, Modebelu C., Onuoha, Blessing C., Nwanjor, Simon O., Okeke, Joel, Osahor, Kate, Chimechefulam, Lilian, Ogomaka, Ann I., Amaechi, Augustine A., Ezenwa, Chika I., Ezike, Monika N., Ikpeama, Chidimma, Nwachukwu, Ogechi, Eriama-Joseph, Austine I., Nwoke, Berthram E. B., Colebunders, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343278/
https://www.ncbi.nlm.nih.gov/pubmed/30670093
http://dx.doi.org/10.1186/s40249-019-0517-9
_version_ 1783389252942299136
author Siewe, Joseph N. F.
Ukaga, Chinyere N.
Nwazor, Ernest O.
Nwoke, Murphy O.
Nwokeji, Modebelu C.
Onuoha, Blessing C.
Nwanjor, Simon O.
Okeke, Joel
Osahor, Kate
Chimechefulam, Lilian
Ogomaka, Ann I.
Amaechi, Augustine A.
Ezenwa, Chika I.
Ezike, Monika N.
Ikpeama, Chidimma
Nwachukwu, Ogechi
Eriama-Joseph, Austine I.
Nwoke, Berthram E. B.
Colebunders, Robert
author_facet Siewe, Joseph N. F.
Ukaga, Chinyere N.
Nwazor, Ernest O.
Nwoke, Murphy O.
Nwokeji, Modebelu C.
Onuoha, Blessing C.
Nwanjor, Simon O.
Okeke, Joel
Osahor, Kate
Chimechefulam, Lilian
Ogomaka, Ann I.
Amaechi, Augustine A.
Ezenwa, Chika I.
Ezike, Monika N.
Ikpeama, Chidimma
Nwachukwu, Ogechi
Eriama-Joseph, Austine I.
Nwoke, Berthram E. B.
Colebunders, Robert
author_sort Siewe, Joseph N. F.
collection PubMed
description BACKGROUND: High epilepsy prevalence and incidence have been reported in areas with high onchocerciasis transmission. Recent findings suggest that proper community-directed treatment with ivermectin (CDTI) is potentially able to prevent onchocerciasis-associated epilepsy (OAE). We assessed the epilepsy prevalence and onchocerciasis transmission in two Nigerian villages following more than 20 years of CDTI. METHODS: A cross-sectional door-to-door survey was performed in two villages in the Imo River Basin reported to be mesoendomic for onchocerciasis (Umuoparaodu and Umuezeala). Individuals were screened for epilepsy using a validated 5-item questionnaire. Persons suspected to have epilepsy were examined by a neurologist or a physician with training in epilepsy for confirmation. Onchocerciasis was investigated via skin snip microscopy and rapid diagnostic tests for Ov16 antibodies. Results were compared with previous findings from the Imo river basin. RESULTS: A total of 843 individuals from 257 households in the two villages were encountered. We detected four persons with epilepsy (PWE) giving a crude epilepsy prevalence of 0.5%. This finding differs from observations reported 14 years ago which showed an epilepsy prevalence of 2.8% in the neighbouring village of Umulolo (P = 0.0001), and 1.2% from 13 villages in the Imo river basin (P = 0.07). The seroprevalence of Ov16 antibodies was found to be 0%. Only 4.6% of skin snips were positive compared to 26.8% in previous surveys (P < 0.0001). Ivermectin mass distribution coverage in the study sites in 2017 was 79.7%. CONCLUSIONS: A low epilepsy and onchocerciasis prevalence was observed following more than 20 years of CDTI in the Imo River Basin. Absence of Ov16 antibodies indicates minimal transmission of onchocerciasis. These results contrast with observations from areas of high onchocerciasis transmission, where epilepsy prevalence and incidence remain high. Findings from this study suggest that sustained efforts could eventually achieve elimination of onchocerciasis in these villages. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40249-019-0517-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6343278
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63432782019-01-24 Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria Siewe, Joseph N. F. Ukaga, Chinyere N. Nwazor, Ernest O. Nwoke, Murphy O. Nwokeji, Modebelu C. Onuoha, Blessing C. Nwanjor, Simon O. Okeke, Joel Osahor, Kate Chimechefulam, Lilian Ogomaka, Ann I. Amaechi, Augustine A. Ezenwa, Chika I. Ezike, Monika N. Ikpeama, Chidimma Nwachukwu, Ogechi Eriama-Joseph, Austine I. Nwoke, Berthram E. B. Colebunders, Robert Infect Dis Poverty Research Article BACKGROUND: High epilepsy prevalence and incidence have been reported in areas with high onchocerciasis transmission. Recent findings suggest that proper community-directed treatment with ivermectin (CDTI) is potentially able to prevent onchocerciasis-associated epilepsy (OAE). We assessed the epilepsy prevalence and onchocerciasis transmission in two Nigerian villages following more than 20 years of CDTI. METHODS: A cross-sectional door-to-door survey was performed in two villages in the Imo River Basin reported to be mesoendomic for onchocerciasis (Umuoparaodu and Umuezeala). Individuals were screened for epilepsy using a validated 5-item questionnaire. Persons suspected to have epilepsy were examined by a neurologist or a physician with training in epilepsy for confirmation. Onchocerciasis was investigated via skin snip microscopy and rapid diagnostic tests for Ov16 antibodies. Results were compared with previous findings from the Imo river basin. RESULTS: A total of 843 individuals from 257 households in the two villages were encountered. We detected four persons with epilepsy (PWE) giving a crude epilepsy prevalence of 0.5%. This finding differs from observations reported 14 years ago which showed an epilepsy prevalence of 2.8% in the neighbouring village of Umulolo (P = 0.0001), and 1.2% from 13 villages in the Imo river basin (P = 0.07). The seroprevalence of Ov16 antibodies was found to be 0%. Only 4.6% of skin snips were positive compared to 26.8% in previous surveys (P < 0.0001). Ivermectin mass distribution coverage in the study sites in 2017 was 79.7%. CONCLUSIONS: A low epilepsy and onchocerciasis prevalence was observed following more than 20 years of CDTI in the Imo River Basin. Absence of Ov16 antibodies indicates minimal transmission of onchocerciasis. These results contrast with observations from areas of high onchocerciasis transmission, where epilepsy prevalence and incidence remain high. Findings from this study suggest that sustained efforts could eventually achieve elimination of onchocerciasis in these villages. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40249-019-0517-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-23 /pmc/articles/PMC6343278/ /pubmed/30670093 http://dx.doi.org/10.1186/s40249-019-0517-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Siewe, Joseph N. F.
Ukaga, Chinyere N.
Nwazor, Ernest O.
Nwoke, Murphy O.
Nwokeji, Modebelu C.
Onuoha, Blessing C.
Nwanjor, Simon O.
Okeke, Joel
Osahor, Kate
Chimechefulam, Lilian
Ogomaka, Ann I.
Amaechi, Augustine A.
Ezenwa, Chika I.
Ezike, Monika N.
Ikpeama, Chidimma
Nwachukwu, Ogechi
Eriama-Joseph, Austine I.
Nwoke, Berthram E. B.
Colebunders, Robert
Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
title Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
title_full Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
title_fullStr Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
title_full_unstemmed Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
title_short Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
title_sort low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the imo river basin in nigeria
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343278/
https://www.ncbi.nlm.nih.gov/pubmed/30670093
http://dx.doi.org/10.1186/s40249-019-0517-9
work_keys_str_mv AT siewejosephnf lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT ukagachinyeren lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT nwazorernesto lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT nwokemurphyo lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT nwokejimodebeluc lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT onuohablessingc lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT nwanjorsimono lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT okekejoel lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT osahorkate lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT chimechefulamlilian lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT ogomakaanni lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT amaechiaugustinea lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT ezenwachikai lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT ezikemonikan lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT ikpeamachidimma lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT nwachukwuogechi lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT eriamajosephaustinei lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT nwokeberthrameb lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria
AT colebundersrobert lowprevalenceofepilepsyandonchocerciasisaftermorethan20yearsofivermectintreatmentintheimoriverbasininnigeria